Rare disease challenges and potential actions in the Middle East.

ABSTRACT:

Background

Rare diseases, defined variably by global regions, collectively impact approximately 300 million individuals despite affecting small population segments individually. Historically there were no treatments developed for these conditions, leading to significant care challenges. Public interventions have incentivized treatment development, yet up to this day, many rare disease patients are deprived of timely diagnosis and treatment in comparison to patients with more common diseases. This study evaluates the challenges that rare disease patients and healthcare systems face in the Middle East and North Africa (MENA), seeking strategies to enhance treatment accessibility.

Methods

We followed a three-step approach for the study. First, we searched scientific publication

SUBMITTER: Fasseeh AN 

PROVIDER: S-EPMC11863865 | biostudies-literature | 2025 Feb

REPOSITORIES: biostudies-literature